logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    
Gilead Sciences Inc.

Gilead Sciences Inc. (GILD)

Follow

Details

Wall

Profile


Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Issuer Information

Exchange: NASDAQ
Market Cap: 85694490248
CEO: John C. Martin
Employees: 5000
Issuer Type: CS
Auditor: Ernst & Young LLP
Last Audit: UQ
CIK: 882095
Sector: Healthcare
Industry: Biotechnology
Sub-Industry: Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturin (325414)
SIC: 2836
Last earning call url:
Slideshare slide url:

Contact Information

Main phone: +1 650 574-3000
Address: 333 Lakeside Drive
Address 2:
State: CA
City / Town: Foster City
Country: USA
Postal Code: 94404
Fax:

Videos

No public videos available.

Blog

No Result Found.

News

Gilead Sciences Inc. (GILD) posted Q2 2014 earnings of $2.36 a share, easily beating the consensus estimate by 58 cents.Sales came in at $6.53 billion, topping earlier estimate by 12%.…
If investors were as practical with their investment portfolio as they are with managing a garden, they might make a lot more money! There are so many analogies between managing…
The biotech bull market is not over. That's the judgment of Reni Benjamin of H.C. Wainwright & Co., who predicts high quality data from a broad range of small- and…
GlobeImmune  (GBIM)  is a biopharmaceutical company established in 1995 focused on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen® platform. It is headquartered…
“The Captain has suggested you wear your safely belt…time to be cautious.” We have had a tremendous ride with the stock market for an extended period of time. Since the…
When progress is made in drug development, value is created. Investors recognize that progress by purchasing shares in companies when milestones—which act as catalysts—are met. The Maxim Group's Senior Managing…
Conatus Pharmaceuticals (CNAT) continues the trend of huge pharmaceutical and biotechnology movers this week, peaking on June 11 at an intraday high of $9.87 a share. The past week has…
Shares of Achillion Pharmaceuticals (ACHN) are roaring ahead in Tuesday action after the U.S. Food and Drug Administration lifted its clinical hold on the Achillion’s experimental drug sovaprevir for treating…
The Food and Drug Administration (FDA) lifted the clinical hold on Achillion Pharmaceuticals Inc.'s (ACHN) study for experimental hepatitis C drug on June 10, eight months after halting the company's research. The…
Monday saw a major tectonic shift in the market for biotech companies. Or, rather, the tectonic shift happened some time ago; Monday was the day a major earthquake finally rippled…

Trending

Social Mentions about your company in the last seven days
Adam Feuerstein
25 Jul 14 04:22:03
RT @AndyBiotech: EMA CHMP July Meeting Highlights http://t.co/9AIcnVWY2u Positive opinions for $PCYC ibrutinib and $GILD idelalisib. http:…
Market News Desk
25 Jul 14 04:21:56
$GILD: Gilead Sciences Director Unloads $448350 in Stock (GILD) http://t.co/8Qli86ZYhL http://t.co/uc9oWbgbHe
Andy Biotech
25 Jul 14 04:21:50
EMA CHMP July Meeting Highlights http://t.co/9AIcnVWY2u Positive opinions for $PCYC ibrutinib and $GILD idelalisib. http://t.co/sx28KNQORo
Ben Silverberg
25 Jul 14 04:21:25
@AndyBiotech $GILD Sovaldi IMS TRx 7,551, down 6% wk/wk; NRx 2,889, down 2% wk/wk for the week ending 7/18/14.
Donna Young
25 Jul 14 04:19:14
#EMA's #CHMP recommends $GILD Zydelig (idelalisib), newly OK'd in US, & $PCYC Imbruvica (ibrutinib) in CLL http://t.co/IQ0S2yGPtj #pharma
Andy Biotech
25 Jul 14 04:18:57
$GILD Sovaldi IMS TRx 7,551, down 6% wk/wk; NRx 2,889, down 2% wk/wk for the week ending 7/18/14.
The Fly
25 Jul 14 04:17:43
$GILD $JNJ EMA recommends approval for Gilead, Janssen blood cancer drugs: Full Story http://t.co/igjpZm2uRM
finsents
25 Jul 14 04:17:33
$GILD:US 25Jul Positive News #Sentiment http://t.co/mpxouP30Cl #Russell200
Tee
25 Jul 14 04:11:58
It only took 6 months for Gilead to pass its 2013 revenue total, all because of Sovaldi $GILD @Carl_C_Icahn,I hope u r interested in GILD
Sicarius
25 Jul 14 03:53:05
Buy $CELG $GILD $CBI on a pull back here.
Tee
25 Jul 14 03:41:43
@jimcramer is it dividend time for $GILD?
H3NPHLO
25 Jul 14 03:39:38
#Sovaldi: Prescr. figures for wk ending 7/18 (Bloomberg/Symphony Health) : TRx@ 6654, NRx@ 2781. $GILD
Bret Jensen
25 Jul 14 03:33:57
Commented on: "2 Stocks That Are Much Cheaper Than They Appear" http://t.co/2pSDpeHVTR $GILD $MU
Fernande Minor
25 Jul 14 03:31:30
$LRCX Are you thinking of selling $SCG $GILD $LIVE Visit RATE_LIMIT_EXCEEDED
CLiverFoundation
25 Jul 14 03:29:46
RT @megtirrell: $GILD says about 9,000 people have been cured of hepatitis C with Sovaldi to date
Bulls vs Bears
25 Jul 14 03:21:54
$GILD: Why Gilead Sciences, inc. Stock Was Flat Today http://t.co/JU93P7dbw7 http://t.co/H2OoacQiG0
iHangout
25 Jul 14 03:15:15
http://t.co/eyohRCZsN5 Stock_Tracker: Stock DD Board: Gilead Sciences (GILD) 90.54 $GILD Why Gilead http://t.co/URKNZyxuRE
Stock_Tracker
25 Jul 14 03:10:48
Gilead Sciences (GILD) 90.54 $GILD Why Gilead Sciences, inc. Stock Was Flat Today Michael Douglass and David W http://t.co/NExciusews
12Stocks.com
25 Jul 14 03:02:43
Weekly S&P500 #Stocks Trend $ISRG $CMG $FB $BIIB $GME $EMC $HBAN $FLS $TSCO $GILD $GCI $CME $IPG $WHR $CTXS @ http://t.co/ppYlnKK6xM
12Stocks.com
25 Jul 14 03:02:11
Weekly Nasdaq100 #Stocks Trend $ISRG $FB $BIIB $BIDU $TSCO $GILD $CTXS $MAR $CTSH $CA $EBAY $SBUX $NTAP $FFIV @ http://t.co/wz4pxpINCJ
12Stocks.com
25 Jul 14 03:01:55
Weekly Nasdaq100 #Stocks Performance $ISRG $FB $BIIB $BIDU $YHOO $ALXN $TSCO $GILD $AMGN $CHKP $CTXS $MAR more@ http://t.co/wz4pxpINCJ
12Stocks.com
25 Jul 14 03:01:40
Weekly S&P100 #Stocks Trend $FB $EMC $GILD $LMT $BK $GD $HAL $EBAY $DOW $SBUX $CVX $CVS $GS $MS $LLY $NSC $JPM @ http://t.co/cKkr8ctphu
12Stocks.com
25 Jul 14 03:01:25
Weekly S&P100 #Stocks Performance $FB $EMC $GILD $AMGN $LMT $BK $GD $HAL $DVN $EBAY $DOW $AAPL $SBUX $WAG more@ http://t.co/cKkr8ctphu
K
25 Jul 14 03:00:54
RT @bensonndehi: $GILD yesterday hit an all-time high of $92.97. The forward P/E is 10.29 assuming future EPS growth is flat. 90.54/(2.2*4)…
medtech[y]
25 Jul 14 03:00:25
Amid #Sovaldi controversy, Gilead crushes earnings. Start a conversation. |http://t.co/el2ozJs86v @GileadSciences $GILD
Stock Market Monitor
25 Jul 14 02:55:46
$GILD: Video: Celgene, Alexion Earnings Top, But Stocks Fall http://t.co/2vwWTwA7VT
Business Reports
25 Jul 14 02:55:44
$GILD: Celgene, Alexion Earnings Top Street, But Stocks Fall http://t.co/SyhKH5EY14
SNN Team
25 Jul 14 02:53:26
$GILD - Celgene, Alexion Earnings Top Street, But Stocks Fall -> http://t.co/8uRrY7Frf8 #stock #stocks #stockaction
SNN Team
25 Jul 14 02:53:08
$GILD - Video: Celgene, Alexion Earnings Top, But Stocks Fall -> http://t.co/DoWXAOyXwZ #stock #stocks #stockaction
necole domville
25 Jul 14 02:52:15
$GILD Get the latest on $TEX $Y $FB #financial RATE_LIMIT_EXCEEDED
Stock Market Monitor
25 Jul 14 02:50:47
$GILD: Biotechs beat estimates, but the Street wants more http://t.co/vDezDXVrvG
4-traders.com
25 Jul 14 02:50:01
Gilead Sciences : Reaps Windfall from $1,000 Hepatitis C Pill http://t.co/Bu0AS5kD5D $GILD
stocknews247
25 Jul 14 02:47:16
$GILD - Biotechs beat estimates, but the Street wants more -> http://t.co/urpvbVm9LN #stock #stocks #stockaction
Точка Входа.Трейдинг
25 Jul 14 02:45:05
Идеи short / / $GILD $EW $DE $LRCX $VRTX / / #трейдинг #nyse #nasdaq
vinita song
25 Jul 14 02:29:53
Are you Investing in $GRA $GILD $LXK $AAPL View now RATE_LIMIT_EXCEEDED
Bianca Chism
25 Jul 14 02:23:32
$SLH Insider Trading updates on $PF $GILD $IBM #liquidity RATE_LIMIT_EXCEEDED
Stock Forums
25 Jul 14 02:19:32
$RITE Financials http://t.co/3p2CXAaxbt Also See: $GILD $RTXB $STLD $EPGL ~
Peter Courtney
25 Jul 14 02:18:03
http://t.co/7t8EWHlvlp Waxman on $GILD: "Their greed is going to be unrestrained"
Business News
25 Jul 14 01:21:54
$GILD: Gilead: Even This Raging Bull Was Too Pessimistic (GILD) http://t.co/bZkuAMKaDV http://t.co/mHW0WpMh56
zipjet
25 Jul 14 01:15:35
@Drchik23 @Colavito00 liver MD friend says S/O combo gold std now 4HCV but will shift to all oral $GILD when FDA approve in Oct, big rev inc
Chasing Stars
25 Jul 14 01:10:44
$HPNN Ask Size http://t.co/ofuMOr1HMV Also See: $QASP $GILD $ILIV $C ~
Chasing Stars
25 Jul 14 01:01:16
$HLF Bid Size http://t.co/Evabb4iNr6 Also See: $ABBV $BIG $GILD $RF ~
Wall Street News
25 Jul 14 00:55:48
$GILD: Gilead Beats Q2 Views On Revenue Growth Lead By Sovaldi Drug http://t.co/8Tj7hXX0se
StockNews24
25 Jul 14 00:51:28
$GILD - Gilead Beats Q2 Views On Revenue Growth Lead By Sovaldi Drug -> http://t.co/6vC0NqLQje #stock #stocks #stockaction
The GMP Group
25 Jul 14 00:47:39
RT @fwpharma: ViewPoints: As another of Gilead's M&A picks crosses the finish line, speculation grows about its next target http://t.co/fwJ…
stocknews247
25 Jul 14 00:47:16
$GILD - [video] FMHR Final Trade: DAL, MCK, GILD & DNR -> http://t.co/m8EjjZVN9B #stock #stocks #stockaction
FirstWord Pharma
25 Jul 14 00:45:38
ViewPoints: As another of Gilead's M&A picks crosses the finish line, speculation grows about its next target http://t.co/fwJlJ3WAdq $GILD
Stock Forums
25 Jul 14 00:42:09
$MTVX Open http://t.co/Y78W0LySvu Also See: $EPGL $GILD $FOXA $AKS ~
The GMP Group
25 Jul 14 00:40:47
RT @fwpharma: Spotlight On: Dissecting Gilead's Q2 results – five key #hepatitis C questions http://t.co/bLtODdeVMQ $GILD
FirstWord Pharma
25 Jul 14 00:40:38
Spotlight On: Dissecting Gilead's Q2 results – five key #hepatitis C questions http://t.co/bLtODdeVMQ $GILD

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.